| Primary |
| Hypertension |
18.6% |
| Hypercholesterolaemia |
17.5% |
| Hyperlipidaemia |
16.5% |
| Coronary Artery Disease |
14.4% |
| Dyslipidaemia |
7.2% |
| Myocardial Infarction |
4.1% |
| Type 2 Diabetes Mellitus |
4.1% |
| Arrhythmia |
3.1% |
| Ischaemic Gastritis |
2.1% |
| Sleep Disorder |
2.1% |
| Aortic Valve Replacement |
1.0% |
| Atrial Fibrillation |
1.0% |
| Benign Prostatic Hyperplasia |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Chronic Lymphocytic Leukaemia |
1.0% |
| Depression |
1.0% |
| Diabetes Mellitus |
1.0% |
| Nephrotic Syndrome |
1.0% |
| Osteoporosis |
1.0% |
| Pancreatitis Acute |
1.0% |
|
| Death |
16.0% |
| Rhabdomyolysis |
10.0% |
| Pyrexia |
8.0% |
| Tendon Rupture |
8.0% |
| Hypertension |
6.0% |
| Autoimmune Hepatitis |
4.0% |
| Breast Disorder Male |
4.0% |
| Dyspnoea |
4.0% |
| General Physical Health Deterioration |
4.0% |
| Liver Disorder |
4.0% |
| Lung Infection |
4.0% |
| Non-hodgkin's Lymphoma |
4.0% |
| Pneumonia |
4.0% |
| Sinus Tachycardia |
4.0% |
| Syncope |
4.0% |
| Type 1 Diabetes Mellitus |
4.0% |
| Abasia |
2.0% |
| Arrhythmia |
2.0% |
| Aspartate Aminotransferase Increased |
2.0% |
| Asthma |
2.0% |
|
| Secondary |
| Hypercholesterolaemia |
22.4% |
| Hypertension |
15.8% |
| Hyperlipidaemia |
10.6% |
| Lipid Metabolism Disorder |
9.2% |
| Drug Use For Unknown Indication |
4.3% |
| Type 2 Diabetes Mellitus |
4.3% |
| Cardiac Failure |
4.0% |
| Diabetes Mellitus |
4.0% |
| Dyslipidaemia |
3.4% |
| Pruritus |
2.9% |
| Type Iia Hyperlipidaemia |
2.9% |
| Heart Transplant |
2.6% |
| Rheumatoid Arthritis |
2.3% |
| Coronary Artery Disease |
2.0% |
| Prophylaxis |
2.0% |
| Low Density Lipoprotein Increased |
1.7% |
| Osteoporosis |
1.7% |
| Type Iib Hyperlipidaemia |
1.4% |
| Gout |
1.1% |
| Ischaemic Cardiomyopathy |
1.1% |
|
| Rhabdomyolysis |
18.6% |
| Pneumonia |
11.4% |
| Malaise |
8.6% |
| Renal Failure Acute |
7.1% |
| Abdominal Discomfort |
5.7% |
| Interstitial Lung Disease |
5.7% |
| Myalgia |
5.7% |
| Pyrexia |
5.7% |
| Rash |
4.3% |
| Skin Burning Sensation |
4.3% |
| Blood Pressure Diastolic Decreased |
2.9% |
| Coronary Artery Thrombosis |
2.9% |
| Left Ventricular Hypertrophy |
2.9% |
| Nervous System Disorder |
2.9% |
| Rhinorrhoea |
2.9% |
| Sinus Bradycardia |
2.9% |
| Abasia |
1.4% |
| Androgenetic Alopecia |
1.4% |
| Autoimmune Hepatitis |
1.4% |
| Blood Alkaline Phosphatase Increased |
1.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.9% |
| Product Used For Unknown Indication |
22.0% |
| Hypertension |
11.2% |
| Hiv Infection |
5.6% |
| Hypercholesterolaemia |
4.9% |
| Non-small Cell Lung Cancer |
4.5% |
| Hyperlipidaemia |
3.6% |
| Rheumatoid Arthritis |
3.4% |
| Type 2 Diabetes Mellitus |
3.3% |
| Pain |
2.1% |
| Renal Transplant |
2.1% |
| Cardiac Failure |
2.0% |
| Coronary Artery Disease |
1.9% |
| Osteoporosis |
1.8% |
| Nasopharyngitis |
1.7% |
| Diabetes Mellitus |
1.5% |
| Hyperparathyroidism Secondary |
1.5% |
| Dyslipidaemia |
1.4% |
| Atrial Fibrillation |
1.3% |
| Bronchitis |
1.2% |
|
| Weight Decreased |
9.9% |
| Renal Failure Acute |
9.0% |
| Vomiting |
9.0% |
| Thrombocytopenia |
8.1% |
| Myocardial Infarction |
7.2% |
| Death |
5.4% |
| General Physical Condition |
5.4% |
| Liver Disorder |
5.4% |
| Rhabdomyolysis |
4.5% |
| Cardiac Failure |
3.6% |
| Hepatic Function Abnormal |
3.6% |
| Intussusception |
3.6% |
| Myalgia |
3.6% |
| Pulmonary Embolism |
3.6% |
| Somnolence |
3.6% |
| Visual Acuity Reduced |
3.6% |
| Atrial Fibrillation |
2.7% |
| Drug Exposure During Pregnancy |
2.7% |
| Drug Interaction |
2.7% |
| Hypotension |
2.7% |
|
| Interacting |
| Angina Pectoris |
16.7% |
| Dyslipidaemia |
16.7% |
| Hypertension |
16.7% |
| Nausea |
16.7% |
| Type 2 Diabetes Mellitus |
16.7% |
| Vomiting |
16.7% |
|
|
